NURC
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
08/19/2025
Back to search
Official data from USPTO
OXYSTEROL THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
OXYSTEROL THERAPEUTICS
ST13
US500000086746639Class
5
Filing
86746639
Registration
5152047
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
42
Latest update
08/19/2025
Trademark type
Word
Nice classes
5
Filing date
09/03/2015
Registration date
02/28/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/28/2017
Last transaction
08/19/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2011-05-00
First use in commerce
2011-05-00
Drawing code
4
Owner type
03
Owner location
Los Angeles, CA
Examiner
VERHOSEK, WILLIAM
Current location
Historical data usage
Holders and representatives
Holders
MAX BioPharma, Inc.
Representatives
MAX BioPharma, Inc.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Therapeutic pharmaceutical for the treatment of osteoporosislocalized bone formation conditionsfor use in oncology
Publications
History of USPTO decisions and trademark events.
42 publications found
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
07/31/2025
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
04/10/2025
XXXX
POST REGISTRATION ACTION CORRECTION
04/08/2025
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
04/07/2025
PRAM
POST REGISTRATION ACTION MAILED - SEC. 7
10/07/2024
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
09/26/2024
PRAM
POST REGISTRATION ACTION MAILED - SEC. 7
04/15/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/08/2024
ES7R
TEAS SECTION 7 REQUEST RECEIVED
08/29/2023
ES8R
TEAS SECTION 8 RECEIVED
08/25/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
02/28/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
02/28/2017
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/25/2017
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/25/2017
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
01/24/2017
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
01/23/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/19/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/19/2017
ALIE
ASSIGNED TO LIE
01/19/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/19/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/29/2016
GNRT
NON-FINAL ACTION E-MAILED
06/29/2016
CNRT
SU - NON-FINAL ACTION - WRITTEN
06/29/2016
SUPC
STATEMENT OF USE PROCESSING COMPLETE
06/24/2016
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
06/23/2016
IUAF
USE AMENDMENT FILED
05/31/2016
EISU
TEAS STATEMENT OF USE RECEIVED
05/31/2016
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
04/26/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/01/2016
PUBO
PUBLISHED FOR OPPOSITION
03/01/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/10/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/04/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/30/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/29/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/29/2015
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/18/2015
GNRT
NON-FINAL ACTION E-MAILED
12/18/2015
CNRT
NON-FINAL ACTION WRITTEN
12/18/2015
DOCK
ASSIGNED TO EXAMINER
12/16/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/09/2015
NWAP
NEW APPLICATION ENTERED
09/07/2015
Continuous trademark protection
Get notified about every new filing that threatens OXYSTEROL THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.